FTC Says AbbVie Must Produce Board Docs In AndroGel Fight
The Federal Trade Commission has asked a Pennsylvania federal judge to order AbbVie Inc. to release documents from its board of directors in a pay-for-delay suit over the testosterone treatment AndroGel,...To view the full article, register now.
Already a subscriber? Click here to view full article